Indications
Treatment of Niemann-Pick disease type C (NPC).
Composition
- Active substance
- arimoclomol citrate
- International name (INN)
- arimoclomol
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Miplyffa
- Active substance
- arimoclomol citrate
- ATC code
- N07
- Group
- Nervous system
- Therapeutic area
- Niemann-Pick Disease, Type C
- Marketing authorisation holder
- Orphazyme A/S
- Status
- Application withdrawn
- EMA product number
- EMEA/H/C/005203